Stay updated with breaking news from Relational Commerce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PDUFA date of September 8, 2022 for DaxibotulinumtoxinA for Injection in glabellar linesReinspection of manufacturing facility completed as part of Class II BLA resubmission for DaxibotulinumtoxinA for Injection in glabellar linesSecond quarter total revenue of $28.4 million, with RHA® Collection revenue of $25.5 mi...
Conference Call Scheduled for Tuesday, August 9, 2022 at 4:30 p.m. ET.NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will release second quarter 2022 fin...
GuruFocus Article or News written by Business Wire and the topic is about:
Press release content from Business Wire. The AP news staff was not involved in its creation.
- BLA for DaxibotulinumtoxinA for Injection remains under FDA review -NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, responds to the public disclosure of its Form 483 pursuant to a Freedom of Information...